Publications by authors named "Naim Shehadeh"

Claim this Profile
R
Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.
Afif Nakhleh, Khaled Khazim, Naim Shehadeh

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonists in adults with cystic fibrosis-related diabetes: Rationale and emerging evidence.
Mai Assalia Naffa, Gida Ayada, Sagit Zolotov, Naim Shehadeh, Afif Nakhleh

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of oral l-arginine alone or in combination with sodium butyrate on glucagon-like peptide-1 secretion in non-diabetic adults with obesity.
Afif Nakhleh, Wasim Said, Salim Hadad, Sagit Zolotov, Naim Shehadeh

Nutr Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biochemical profile of individuals with renal glucosuria: A matched cohort study.
Afif Nakhleh, Limor Adler, Gida Ayada, Shirley Shapiro Ben David, Daniella Rahamim-Cohen, Naim Shehadeh

Diabetes Obes Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up).
Naim Shehadeh, Pietro Galassetti, Nayyar Iqbal, Cecilia Karlsson, John Monyak

J Clin Endocrinol Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report.
Gida Ayada, Sagit Zolotov, Raya Cohen, Tal Lavi, Muhammad Abdul-Ghani, Naim Shehadeh

Diabetes Technol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis and Visualization of Confounders and Treatment Pathways Leading to Amputation and Non-Amputation in Peripheral Artery Disease Patients Using Sankey Diagrams: Enhancing Explainability.
Rajashekar Korutla, Douglas Tedder, Kathryn Brogan, Marko Milosevic, Michael P Wilczek, Naim Shehadeh

Biomedicines· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary.
Naim Shehadeh

Curr Med Res Opin· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism.
Afif Nakhleh, Naim Shehadeh, Bshara Mansour

Pituitary· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
Afif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, Adi Gross, Idit Livnat, Naim Shehadeh

Diabetes Obes Metab· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission of type 2 diabetes mellitus.
Afif Nakhleh, Elya Halfin, Naim Shehadeh

World J Diabetes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review.
Afif Nakhleh, Jomana Mazareeb, Said Darawshi, Amin Masri, Naim Shehadeh

Clin Med Insights Endocrinol Diabetes· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes.
Naim Shehadeh, Timothy Barrett, Pietro Galassetti, Cecilia Karlsson, John Monyak

NEJM Evid· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review.
William Tamborlane, Naim Shehadeh

Adv Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study.
Afif Nakhleh, Areen Othman, Amin Masri, Moshe Zloczower, Sagit Zolotov, Naim Shehadeh

Biomedicines· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).
Afif Nakhleh, Mirela Goldenberg-Furmanov, Rayna Goldstein, Mordechai Shohat, Naim Shehadeh

J Diabetes Complications· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education.
Afif Nakhleh, Sivan Spitzer, Naim Shehadeh

Diabetes Technol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice.
Tomer Adar, Meir Mizrahi, Yoav Lichtenstein, Yehudit Shabat, Rizan Sakhnini, Naim Shehadeh

Clin Exp Hepatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiometabolic risk factors among children and adolescents with overweight and Class 1 obesity: A cross-sectional study. Insights from stratification of Class 1 obesity.
Afif Nakhleh, Rizan Sakhnini, Eyal Furman, Naim Shehadeh

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassays.
Afif Nakhleh, Leonard Saiegh, Naim Shehadeh, Naomi Weintrob, Mohammad Sheikh-Ahmad

Front Endocrinol (Lausanne)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cultural and Digital Health Literacy Appropriateness of App- and Web-Based Systems Designed for Pregnant Women With Gestational Diabetes Mellitus: Scoping Review.
Yosefa Birati, Enav Yefet, Yuri Perlitz, Naim Shehadeh, Sivan Spitzer

J Med Internet Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Youth-onset type 2 diabetes in Israel: A national cohort.
Nehama Zuckerman Levin, Meidan Cohen, Moshe Phillip, Ariel Tenenbaum, Ilana Koren, Naim Shehadeh

Pediatr Diabetes· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Exenatide in Youth With Type 2 Diabetes.
William V Tamborlane, Raafat Bishai, David Geller, Naim Shehadeh, Dalia Al-Abdulrazzaq

Diabetes Care· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.
William V Tamborlane, Lori M Laffel, Naim Shehadeh, Elvira Isganaitis, Michelle Van Name

Lancet Diabetes Endocrinol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention.
Afif Nakhleh, Naim Shehadeh

World J Diabetes· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis